APLASTIC ANEMIA
Clinical trials for APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for rare bone marrow disease
Disease control CompletedThis study tested a new 9-day treatment plan for people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. The treatment combined three drugs: rabbit antithymocyte globulin, cyclosporine, and levamisole. The goal was to see if thi…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New hope for rare blood disorder: drug boosts blood cell production
Disease control CompletedThis study tested a drug called eltrombopag in 20 Chinese adults with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. The goal was to see if the drug could improve blood cell counts and reduce the need for transfusions. Participants…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New drug combo shows promise for rare bone marrow failure
Disease control CompletedThis study tested a combination of rabbit antithymocyte globulin (ATG) and ciclosporin in 35 people with acquired aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal was to see if this treatment could improve blood counts and reduce the ne…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: European Society for Blood and Marrow Transplantation • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. The approach uses chemotherapy and radiation before donor stem cells are given, followed by drugs to prevent graft-versus-host disease. The goal was to control the cancer a…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Double transplant from same donor could reduce lifelong Anti-Rejection drugs
Disease control CompletedThis study tested a combined bone marrow and kidney transplant from a partially matched related donor for 10 people with both a blood disorder and chronic kidney disease. The goal was to treat both conditions and possibly reduce the need for lifelong anti-rejection drugs after th…
Matched conditions: APLASTIC ANEMIA
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant for 62 people with high-risk blood cancers like leukemia and lymphoma. First, patients got low-dose chemotherapy and radiation to prepare the body. Then, they received donor immune cells followed by a stem cell transplant. The goa…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New combo therapy shows promise for kids with rare bone marrow failure
Disease control CompletedThis study reviewed medical records of 13 Korean children with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. Researchers wanted to see if adding eltrombopag to standard immunosuppressive therapy was safe and effective over 6 months. Th…
Matched conditions: APLASTIC ANEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New hope for anemia patients: drug duo boosts blood counts
Disease control CompletedThis study tested whether adding luspatercept to standard cyclosporine treatment helps people with non-severe aplastic anemia, a rare condition where the bone marrow doesn't make enough blood cells. 58 newly diagnosed adults who did not need blood transfusions took part. The goal…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Personalized plans may boost transplant survival in seniors
Knowledge-focused CompletedThis study tested a personalized geriatric optimization plan (GO!) in 30 patients aged 60 and older who were getting a stem cell transplant for blood cancers or bone marrow failure. The plan included tailored changes to diet, sleep, activity, and medications. The goal was to see …
Matched conditions: APLASTIC ANEMIA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC